RETN and cancer: The novel research demonstrated that overexpression of microRNA (miRNA), e.g., pre-let-7a, pre-miR-200c, and pre-miR-186 attenuated resistin action in ovarian cancer, leading to epithelial-to-mesenchymal transition, which is a hallmark of cancer cell migration [72].